Percutaneous mitral valve repair in recurrent severe mitral valve regurgitation after mitral annuloplasty
| العنوان: | Percutaneous mitral valve repair in recurrent severe mitral valve regurgitation after mitral annuloplasty |
|---|---|
| المؤلفون: | Nicolas A. Geis, Hugo A. Katus, Haitham Abu-Sharar, Michael M. Kreusser, Christian Sebening, Sven T. Pleger, Philip Raake, Gábor Szabó |
| المصدر: | Herz. 46:54-60 |
| بيانات النشر: | Springer Science and Business Media LLC, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | medicine.medical_specialty, business.industry, MitraClip, Regurgitation (circulation), 030204 cardiovascular system & hematology, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, medicine.anatomical_structure, Mitral valve stenosis, Aortic valve replacement, Cardiothoracic surgery, Internal medicine, Mitral valve, medicine, Cardiology, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, Mitral valve regurgitation, business, Percutaneous Mitral Valve Repair |
| الوصف: | Patients with reduced left ventricular (LV) function undergoing coronary artery bypass graft surgery or/and aortic valve replacement occasionally show severe mitral valve (MV) regurgitation and thus also undergo surgical mitral annuloplasty. Over time, further deterioration of LV function and additional ischemic events cause recurrence of severe MV regurgitation due to the Carpentier IIIb morphology of the MV that is not adequately addressed by the previously implanted annuloplasty ring. Seven patients (Society of Thoracic Surgeons score: 7.5 ± 1.5%) with Carpentier type-IIIb recurrent severe MV regurgitation, having undergone prior cardiothoracic surgery (median: 40 months) including mitral annuloplasty, were treated with the MitraClip device. MitraClip implantation resulted in significantly reduced MV regurgitation and improved New York Heart Association functional state, translating into an increased exercise capability and improved cardiac biomarkers. The morphology of the MV was adequately addressed without causing relevant MV stenosis, while the MV annulus area remained unaltered. The procedure was safe with a 30-day mortality rate of 0%. MitraClip-in-the-ring is feasible and in principle safe for treating Carpentier type IIIb severe MV regurgitation after surgical MV repair using mitral annuloplasty. MitraClip-in-the-ring resulted in immediate amelioration of clinical symptoms and increased physical exercise capacity. |
| تدمد: | 1615-6692 0340-9937 |
| DOI: | 10.1007/s00059-019-04868-0 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::21972cef203d6c60d03e1b1d6364b187 https://doi.org/10.1007/s00059-019-04868-0 |
| Rights: | CLOSED |
| رقم الانضمام: | edsair.doi...........21972cef203d6c60d03e1b1d6364b187 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 16156692 03409937 |
|---|---|
| DOI: | 10.1007/s00059-019-04868-0 |